A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2004
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525909A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	CA2525868A1 Anxiety treatments with ziprasidone
11/25/2004	CA2525866A1 Treatment of psychotic and depressive disorders
11/25/2004	CA2525860A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	CA2525849A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	CA2525526A1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression
11/25/2004	CA2525496A1 Statine derivatives for the treatment of alzheimer's disease
11/25/2004	CA2525366A1 Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
11/25/2004	CA2525326A1 Treatment of bipolar disorders and associated symptoms
11/25/2004	CA2525323A1 Method for enhancing cognition using ziprasidone
11/25/2004	CA2524883A1 Potassium-chloride cotransporter kcc2 modulation for treatment of pain
11/25/2004	CA2524036A1 Treatment of neurodegenerative conditions
11/25/2004	CA2523959A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/24/2004	EP1480445A2 Bit mask generation system and printer drivers and printing methods incorporating bit masks generated utilising same
11/24/2004	EP1479772A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479684A1 Thienopyrimidines, process for preparing the same and use thereof
11/24/2004	EP1479671A1 Pyrimidinone compounds
11/24/2004	EP1479670A1 Novel fused ring indazole compounds
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1479396A1 Drugs ameliorating circadian rhythum disorder
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478648A2 Phosphorus-containing compounds uses thereof
11/24/2004	EP1478646A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478643A1 5-heteroaryl substituted indoles
11/24/2004	EP1478638A1 Purification of citalopram
11/24/2004	EP1478637A1 Amorphous citalopram salts
11/24/2004	EP1478636A1 Amorphous citalopram
11/24/2004	EP1478635A1 Process for the production of citalopram
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478622A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n- 2 n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl -ethylpyrrolidine
11/24/2004	EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478420A1 Dose dispensing system and apparatus
11/24/2004	EP1478400A1 Therapy for the treatment of migraine comprising anticonvulsant derivatives and antimigraine agents
11/24/2004	EP1478397A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478389A1 Treatment for diseases of the eye, inner ear and central nervous system
11/24/2004	EP1478384A2 Method for increasing the survival of dopamine secreting cells
11/24/2004	EP1478382A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
11/24/2004	EP1478380A2 Use of tyrosine kinase inhibitors for treating cns disorders
11/24/2004	EP1478378A2 Anti-allergic complex molecules
11/24/2004	EP1478374A1 Formulations comprising psychotropic drugs and selenium
11/24/2004	EP1478366A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1478356A2 Therapeutic compounds
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1478236A2 Targeted retrograde gene delivery to motor neurons
11/24/2004	EP1313496B1 Use of a composition comprising an extract of pollen for the treatment of edema
11/24/2004	EP1313495B1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
11/24/2004	EP1313493B1 Use of a composition comprising an extract of pollen for the treatment of irritability
11/24/2004	EP1313492B1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
11/24/2004	EP1307201B1 Selective pde 2 inhibitors, used as medicaments for improving cognition
11/24/2004	EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/24/2004	EP1285000B1 Adnf mixtures for enhancing learning and memory
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1200470B1 Globular assembly of amyloid beta protein and uses thereof
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1135519A4 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
11/24/2004	EP1109572A4 Neuroprotection
11/24/2004	EP1100465B1 Medicinal aerosol formulations
11/24/2004	EP1098655B1 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
11/24/2004	EP1014886B1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
11/24/2004	EP0960111B1 Morphine derivatives with analgesic activity
11/24/2004	EP0889731B1 Injectable therapy for control of muscle spasms and pain related to muscle spasms
11/24/2004	CN1549856A Method for differentiating mesenchymal stem cells into neural cells
11/24/2004	CN1549824A Peptidic compounds selectively binding to p-selectin
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004	CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549721A Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/24/2004	CN1549719A Use of pregnane-diones or diols as neuropathic analgesic agents
11/24/2004	CN1549718A Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries
11/24/2004	CN1549715A Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004	CN1549705A Extended release oral dosage form
11/24/2004	CN1548444A Synergistic precursor medicine compound for treating Alzheimer disease
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548434A Benzothiophene compounds and their prepn and medicine use
11/24/2004	CN1548151A Combined biological medicine with active enzyme
11/24/2004	CN1548147A Medicine composition for treating senile dementia
11/24/2004	CN1548144A Sobering-up prepn and its prepn process
11/24/2004	CN1548126A Brain nourishing health article
11/24/2004	CN1548094A Head-wind syndrome treating gastrodia tuber bolus and its prepn
11/24/2004	CN1548072A Pharmaceutical use of asafetida
11/24/2004	CN1548053A New use of baicalin as medicine for treating anxiety neurosis
11/24/2004	CN1548050A Sobering-up liver-protecting medicine composition for preventing chemical liver damage and its prepn process
11/24/2004	CN1548042A Prepn process and formulation of compound Meclofenoxate-Piracetam prepn
11/24/2004	CN1548038A New acetaminophen prepn
11/24/2004	CN1548037A Asafetida extract and its pharmaceutical use

1 ... 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 ... 1833